# Biotech Daily Digest — 2026-01-15

**29 items from 3 sources**

## Summary by Source

- Endpoints News: 8 items
- Fierce Biotech: 5 items
- arXiv q-bio: 16 items


## Endpoints News

- **[FDA to meet Novo Nordisk on troubled site; AbbVie buys drug-device factory](https://endpoints.news/fda-to-meet-novo-nordisk-on-troubled-site-abbvie-buys-drug-device-factory/)**  
  _Thu, 15 Jan 2026 13:52:56 +0000_  
  The FDA is set to meet with Novo Nordisk sometime early this year to discuss the progress made at its troubled Indiana facility, formerly run by Catalent. This is according to ...

- **[Ocugen touts Phase 2 data for eye disease gene therapy](https://endpoints.news/ocugen-touts-phase-2-data-for-eye-disease-gene-therapy/)**  
  _Thu, 15 Jan 2026 13:15:39 +0000_  
  Eye disease gene therapy developer Ocugen reported positive interim Phase 2 data for its geographic atrophy program from a small number of patients.

 Researchers were testing two different dose levels of the experimental therapy, which ...

- **[J&J reports positive Phase 3 data for Tecvayli in earlier blood cancer setting](https://endpoints.news/jj-reports-positive-phase-3-data-for-tecvayli-in-earlier-blood-cancer-setting/)**  
  _Thu, 15 Jan 2026 11:52:54 +0000_  
  Johnson & Johnson’s Tecvayli has achieved survival outcomes in a Phase 3 trial that bode well for its ambitions to expand its use to earlier lines of multiple myeloma.

 The MajesTEC-9 study enrolled patients with ...

- **[Novo Nordisk Foundation to inject $850M+ into BioInnovation Institute through 2035](https://endpoints.news/novo-nordisk-foundation-to-inject-850m-into-bioinnovation-institute-through-2035/)**  
  _Thu, 15 Jan 2026 08:30:28 +0000_  
  The Novo Nordisk Foundation is committing 5.5 billion Danish krone ($857 million) to a life science and deep tech incubator called the BioInnovation Institute from 2026 through 2035.

 The funding will allow the institute, also ...

- **[Scribe Therapeutics plans to test cholesterol-lowering therapy this summer](https://endpoints.news/scribe-therapeutics-plans-to-test-cholesterol-lowering-therapy-this-summer/)**  
  _Wed, 14 Jan 2026 21:11:18 +0000_  
  Scribe Therapeutics, founded almost nine years ago to develop medicines based on novel CRISPR enzymes, is getting ready to test its first therapy in the clinic this summer, the gene editing startup told Endpoints News ...

- **[Jazz sells priority review voucher for $200M, scoring highest price in a decade](https://endpoints.news/jazz-sells-priority-review-voucher-for-200m-scoring-highest-price-in-a-decade/)**  
  _Wed, 14 Jan 2026 18:44:04 +0000_  
  Jazz Pharmaceuticals said it sold a priority review voucher to an undisclosed company for $200 million, landing the highest price for such a voucher since 2016.

 Jazz will take home half ...

- **[#JPM26: Drugmakers want US reforms, not to slow down China](https://endpoints.news/jpm26-drugmakers-want-us-reforms-not-to-slow-down-china/)**  
  _Wed, 14 Jan 2026 16:10:57 +0000_  
  SAN FRANCISCO — Pfizer CEO Albert Bourla and other prominent industry figures at the JP Morgan Healthcare Conference urged US reforms to keep up with China, rather than protectionism.

 If China’s rise was the

- **[Thermo Fisher to lay off 421 workers as it winds down lab product site in North Carolina](https://endpoints.news/thermo-fisher-to-lay-off-421-workers-as-it-winds-down-lab-product-site-in-north-carolina/)**  
  _Wed, 14 Jan 2026 15:59:10 +0000_  
  Thermo Fisher will be phasing out operations at its laboratory products factory in Asheville, NC by the end of 2026. And the service provider will be laying off 421 employees, according to a WARN  ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/italys-alfasigma-pens-eu125m-deal-injectable-form-german-biotechs-hsv-treatment" hreflang="en">Italy's Alfasigma pens €125M deal for injectable form of German biotech's HSV treatment</a>](https://www.fiercebiotech.com/biotech/italys-alfasigma-pens-eu125m-deal-injectable-form-german-biotechs-hsv-treatment)**  
  _Jan 15, 2026 5:48am_  
  Italian pharma Alfasigma has penned a 125 million euros ($145 million) deal for the rights to an injectable form of an investigational HSV encephalitis treatment.

- **[<a href="https://www.fiercebiotech.com/biotech/all-meetings-none-mega-deals-jpms-purpose-evolving" hreflang="en">All the meetings, none of the megadeals: Is JPM's purpose evolving?</a>](https://www.fiercebiotech.com/biotech/all-meetings-none-mega-deals-jpms-purpose-evolving)**  
  _Jan 15, 2026 12:26am_  
  Hopes were high Wednesday for a billion-dollar megadeal—the kind the J.P. Morgan Healthcare Conference is known for—but no major deals ever materialized.

- **[<a href="https://www.fiercebiotech.com/biotech/novo-nordisk-foundation-invests-860m-institute-nurturing-homegrown-biotechs" hreflang="en">Novo Nordisk Foundation invests $860M in Danish institute nurturing homegrown biotechs</a>](https://www.fiercebiotech.com/biotech/novo-nordisk-foundation-invests-860m-institute-nurturing-homegrown-biotechs)**  
  _Jan 14, 2026 5:37am_  
  The Novo Nordisk Foundation is investing 5.5 billion Danish kroner in the BioInnovation Institute to help scale up more homegrown biotechs and deep tech companies.

- **[<a href="https://www.fiercebiotech.com/biotech/jpm26-day-3-gileads-cmo-talks-virus-strategy" hreflang="en">JPM26, Day 3: Hundreds attend Biotech CEO Sisterhood meetup; Novartis CMO on why China's speed is hard to compare to US</a>](https://www.fiercebiotech.com/biotech/jpm26-day-3-gileads-cmo-talks-virus-strategy)**  
  _Jan 14, 2026 9:58am_  
  The J.P. Morgan Healthcare Conference, as well as Fierce's own JPM Week, roll into Wednesday with plenty more events, interviews and panels still to come. Our reporters and editors are on the ground in San Francisco and will keep you updated with all the latest.

- **[<a href="https://www.fiercebiotech.com/biotech/jpm26-after-important-year-sanofi-looks-ahead-remaining-federal-challenges" hreflang="en">JPM26: With pricing deal in the books, Sanofi steels against lingering policy unknowns</a>](https://www.fiercebiotech.com/biotech/jpm26-after-important-year-sanofi-looks-ahead-remaining-federal-challenges)**  
  _Jan 14, 2026 2:30pm_  
  With a White House drug pricing deal done and dusted and the threat of tariffs ameliorated, Sanofi is now enjoying more clarity from the federal government than at the same time last year. But several concerns still linger for the French pharma as the calendar turns to 2026.


## arXiv q-bio

- **[Simulations Predict Improved Valve Performance Without Direct Leaflet Intervention After Neonatal Truncus Arteriosus Repair](https://arxiv.org/abs/2601.08932)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08932v1 Announce Type: new 
Abstract: Truncus arteriosus (TA) is a rare and severe congenital heart disease. Quadricuspid valve morphology occurs in 25% of all TA patients and is linked to regurgitation and increased risk of re-operation. It remains unclear how hemodynamic changes after TA repair alter valv…

- **[Stability and robustness of a generalized pump-leak model for epithelial cell and lumen volume regulation](https://arxiv.org/abs/2601.08975)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08975v1 Announce Type: new 
Abstract: Epithelial cells regulate ion concentrations and volume through coordinated membrane pumps, ion channels, and paracellular pathways which can be modeled by classical single-compartment pump-leak equations (PLEs). Many epithelial functions, however, depend on the interac…

- **[Mapping Connectomic Structure to Function(s) in Cerebellar-like Networks using Kernel Regression](https://arxiv.org/abs/2601.09320)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2601.09320v1 Announce Type: new 
Abstract: Cerebellar-like networks, in which input activity patterns are separated by projection to a much higher-dimensional space before classification, are a recurring neurobiological motif, present in the cerebellum, dentate gyrus, insect olfactory system, and electrosensory…

- **[Evolutionary tuning of TAM receptor-ligand interfaces highlights electrostatic features associated with regenerative phagocytic signaling](https://arxiv.org/abs/2601.08855)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08855v1 Announce Type: cross 
Abstract: Efficient resolution of neuroinflammation and debris clearance is a key determinant of successful central nervous system regeneration. Regenerative vertebrates such as Danio rerio often exhibit faster immune resolution and debris clearance than mammals, yet the molecu…

- **[Semiparametric estimation of GLMs with interval-censored covariates via an augmented Turnbull estimator](https://arxiv.org/abs/2601.08996)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08996v1 Announce Type: cross 
Abstract: Interval-censored covariates are frequently encountered in biomedical studies, particularly in time-to-event data or when measurements are subject to detection or quantification limits. Yet, the estimation of regression models with interval-censored covariates remains…

- **[Fisher's fundamental theorem and regression in causal analysis](https://arxiv.org/abs/2601.09011)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2601.09011v1 Announce Type: cross 
Abstract: Fisher's fundamental theorem describes the change caused by natural selection as the change in gene frequencies multiplied by the partial regression coefficients for the average effects of genes on fitness. Fisher's result has generated extensive controversy in biolog…

- **[Geometric Stability: The Missing Axis of Representations](https://arxiv.org/abs/2601.09173)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2601.09173v1 Announce Type: cross 
Abstract: Analysis of learned representations has a blind spot: it focuses on $similarity$, measuring how closely embeddings align with external references, but similarity reveals only what is represented, not whether that structure is robust. We introduce $geometric$ $stabilit…

- **[Gene genealogies in haploid populations evolving according to sweepstakes reproduction](https://arxiv.org/abs/2601.09537)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2601.09537v1 Announce Type: cross 
Abstract: Sweepstakes reproduction may be generated by chance matching of reproduction with favorable environmental conditions. Gene genealogies generated by sweepstakes reproduction are in the domain of attraction of multiple-merger coalescents where a random number of lineage…

- **[Constitutive parameter inference using physics-based data-driven modeling in full volume datasets of intact and torn rotator cuff tendons](https://arxiv.org/abs/2601.09660)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2601.09660v1 Announce Type: cross 
Abstract: In this work, we characterized the material properties of an animal model of the rotator cuff tendon using full volume datasets of both its intact and injured states by capturing internal strain behavior throughout the tendon. Our experimental setup, involving tension…

- **[SGAC: A Graph Neural Network Framework for Imbalanced and Structure-Aware AMP Classification](https://arxiv.org/abs/2412.16276)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2412.16276v2 Announce Type: replace 
Abstract: Classifying Antimicrobial Peptides (AMPs) from the vast collection of peptides derived from metagenomic sequencing offers a promising avenue for combating antibiotic resistance. However, most existing AMP classification methods rely primarily on sequence-based repre…

- **[Assessing metadata privacy in neuroimaging](https://arxiv.org/abs/2509.15278)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2509.15278v2 Announce Type: replace 
Abstract: The ethical and legal imperative to share research data without causing harm requires careful attention to privacy risks. While mounting evidence demonstrates that data sharing benefits science, legitimate concerns persist regarding the potential leakage of personal…

- **[A Hypothesis-First Framework for Mechanistic Modeling in Neuroimaging](https://arxiv.org/abs/2509.16070)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2509.16070v2 Announce Type: replace 
Abstract: Turning rich neuroimaging data into mechanistic insight remains challenging. Statistical models capture associations but remain largely agnostic to underlying mechanisms. Biophysical models embody candidate mechanisms but remain difficult to deploy without specializ…

- **[Unsupervised full-field Bayesian inference of orthotropic hyperelasticity from a single biaxial test: a myocardial case study](https://arxiv.org/abs/2510.09498)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2510.09498v2 Announce Type: replace 
Abstract: Cardiac muscle tissue exhibits highly non-linear hyperelastic and orthotropic material behavior during passive deformation. Traditional constitutive identification protocols therefore combine multiple loading modes and typically require multiple specimens and substa…

- **[geohabnet: An R package for mapping habitat connectivity for biosecurity and conservation](https://arxiv.org/abs/2510.24955)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2510.24955v2 Announce Type: replace 
Abstract: Mapping habitat suitability, based on factors like host availability and environmental suitability, is a common approach to determining which locations are important for the spread of a species. Mapping habitat connectivity takes geographic analyses a step further,…

- **[Graph Neural Network Surrogates to leverage Mechanistic Expert Knowledge towards Reliable and Immediate Pandemic Response](https://arxiv.org/abs/2411.06500)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2411.06500v4 Announce Type: replace-cross 
Abstract: During the COVID-19 crisis, mechanistic models have guided evidence-based decision making. However, time-critical decisions in a dynamical environment limit the time available to gather supporting evidence. We address this bottleneck by developing a graph neur…

- **[Training Large Neural Networks With Low-Dimensional Error Feedback](https://arxiv.org/abs/2502.20580)**  
  _Thu, 15 Jan 2026 00:00:00 -0500_  
  arXiv:2502.20580v4 Announce Type: replace-cross 
Abstract: Training deep neural networks typically relies on backpropagating high dimensional error signals a computationally intensive process with little evidence supporting its implementation in the brain. However, since most tasks involve low-dimensional outputs, we…
